BIOT — Bioter SA Income Statement
0.000.00%
Last trade - 00:00
- €4.58m
- €178.18m
- €0.25m
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.177 | 0.25 | 0.228 | 0.246 | 0.252 |
Cost of Revenue | |||||
Gross Profit | -4.99 | -3.73 | -1.45 | -0.935 | -0.015 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 5.96 | 2.74 | -16.7 | 0.197 | 0.188 |
Operating Profit | -5.79 | -2.49 | 16.9 | 0.049 | 0.064 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -13 | -7.96 | 6.94 | -8.8 | -9.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | -13.2 | -8.98 | 5.92 | -8.82 | -9.66 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -12.8 | -8.89 | 6.06 | -8.81 | -9.68 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -12.8 | -8.89 | 6.06 | -8.81 | -9.68 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.766 | -0.532 | 0.345 | -0.539 | -0.606 |
Dividends per Share |